236 related articles for article (PubMed ID: 30038614)
1. A Mutation Outside the Dimerization Domain Causing Atypical STING-Associated Vasculopathy With Onset in Infancy.
Saldanha RG; Balka KR; Davidson S; Wainstein BK; Wong M; Macintosh R; Loo CKC; Weber MA; Kamath V; ; ; Moghaddas F; De Nardo D; Gray PE; Masters SL
Front Immunol; 2018; 9():1535. PubMed ID: 30038614
[TBL] [Abstract][Full Text] [Related]
2. A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report.
Weidler S; Koss S; Wolf C; Lucas N; Brunner J; Lee-Kirsch MA
Pediatr Rheumatol Online J; 2024 Jan; 22(1):9. PubMed ID: 38178067
[TBL] [Abstract][Full Text] [Related]
3. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.
Frémond ML; Hadchouel A; Berteloot L; Melki I; Bresson V; Barnabei L; Jeremiah N; Belot A; Bondet V; Brocq O; Chan D; Dagher R; Dubus JC; Duffy D; Feuillet-Soummer S; Fusaro M; Gattorno M; Insalaco A; Jeziorski E; Kitabayashi N; Lopez-Corbeto M; Mazingue F; Morren MA; Rice GI; Rivière JG; Seabra L; Sirvente J; Soler-Palacin P; Stremler-Le Bel N; Thouvenin G; Thumerelle C; Van Aerde E; Volpi S; Willcocks S; Wouters C; Breton S; Molina T; Bader-Meunier B; Moshous D; Fischer A; Blanche S; Rieux-Laucat F; Crow YJ; Neven B
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):803-818.e11. PubMed ID: 33217613
[TBL] [Abstract][Full Text] [Related]
4. STING-associated vasculopathy with onset in infancy: a familial case series report and literature review.
Wang Y; Wang F; Zhang X
Ann Transl Med; 2021 Jan; 9(2):176. PubMed ID: 33569478
[TBL] [Abstract][Full Text] [Related]
5. A case of STING-associated vasculopathy with onset in infancy with novel STING1 variant.
Barry KK; Kranseler JS; Robinson SN
Pediatr Dermatol; 2024 Feb; ():. PubMed ID: 38369300
[TBL] [Abstract][Full Text] [Related]
6. Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).
David C; Frémond ML
Cells; 2022 Jan; 11(3):. PubMed ID: 35159128
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases.
Wan R; Fänder J; Zakaraia I; Lee-Kirsch MA; Wolf C; Lucas N; Olfe LI; Hendrich C; Jonigk D; Holzinger D; Steindor M; Schmidt G; Davenport C; Klemann C; Schwerk N; Griese M; Schlegelberger B; Stehling F; Happle C; Auber B; Steinemann D; Wetzke M; von Hardenberg S
Front Immunol; 2022; 13():1029423. PubMed ID: 36275728
[TBL] [Abstract][Full Text] [Related]
8. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ
J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229
[TBL] [Abstract][Full Text] [Related]
9. Use of Tofacitinib for infant-onset STING-associated vasculopathy: A case report from China.
Shen D; Fan X; Zhou Q; Xu X; Lu M
Medicine (Baltimore); 2022 Dec; 101(48):e31832. PubMed ID: 36482559
[TBL] [Abstract][Full Text] [Related]
10. Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
Frémond ML; Uggenti C; Van Eyck L; Melki I; Bondet V; Kitabayashi N; Hertel C; Hayday A; Neven B; Rose Y; Duffy D; Crow YJ; Rodero MP
Arthritis Rheumatol; 2017 Jul; 69(7):1495-1501. PubMed ID: 28426911
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Novel SAVI-Causing Variants in
Lin B; Torreggiani S; Kahle D; Rumsey DG; Wright BL; Montes-Cano MA; Silveira LF; Alehashemi S; Mitchell J; Aue AG; Ji Z; Jin T; de Jesus AA; Goldbach-Mansky R
Front Immunol; 2021; 12():636225. PubMed ID: 33833757
[TBL] [Abstract][Full Text] [Related]
12. Activated STING in a vascular and pulmonary syndrome.
Liu Y; Jesus AA; Marrero B; Yang D; Ramsey SE; Sanchez GAM; Tenbrock K; Wittkowski H; Jones OY; Kuehn HS; Lee CR; DiMattia MA; Cowen EW; Gonzalez B; Palmer I; DiGiovanna JJ; Biancotto A; Kim H; Tsai WL; Trier AM; Huang Y; Stone DL; Hill S; Kim HJ; St Hilaire C; Gurprasad S; Plass N; Chapelle D; Horkayne-Szakaly I; Foell D; Barysenka A; Candotti F; Holland SM; Hughes JD; Mehmet H; Issekutz AC; Raffeld M; McElwee J; Fontana JR; Minniti CP; Moir S; Kastner DL; Gadina M; Steven AC; Wingfield PT; Brooks SR; Rosenzweig SD; Fleisher TA; Deng Z; Boehm M; Paller AS; Goldbach-Mansky R
N Engl J Med; 2014 Aug; 371(6):507-518. PubMed ID: 25029335
[TBL] [Abstract][Full Text] [Related]
13. [Stimulator of interferon genes-associated vasculopathy with onset in infancy: first case report in China].
Yu ZX; Zhong LQ; Song HM; Wang CY; Wang W; Li J; Ma MS
Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):179-185. PubMed ID: 29518827
[No Abstract] [Full Text] [Related]
14. The activity of disease-causative STING variants can be suppressed by wild-type STING through heterocomplex formation.
Shindo R; Kuchitsu Y; Mukai K; Taguchi T
Front Cell Dev Biol; 2022; 10():1037999. PubMed ID: 36438571
[TBL] [Abstract][Full Text] [Related]
15. Novel TMEM173 Mutation and the Role of Disease Modifying Alleles.
Keskitalo S; Haapaniemi E; Einarsdottir E; Rajamäki K; Heikkilä H; Ilander M; Pöyhönen M; Morgunova E; Hokynar K; Lagström S; Kivirikko S; Mustjoki S; Eklund K; Saarela J; Kere J; Seppänen MRJ; Ranki A; Hannula-Jouppi K; Varjosalo M
Front Immunol; 2019; 10():2770. PubMed ID: 31866997
[TBL] [Abstract][Full Text] [Related]
16. STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions.
Latour-Álvarez I; Murcia-Clemente L; Vázquez-Pigueras I; Garramone-Ramírez JE; Clemente D; Sanz V; Torrelo A
Pediatr Dermatol; 2024 Apr; ():. PubMed ID: 38682895
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Acute Thrombotic Microangiopathy in a Patient with STING-Associated Vasculopathy with Onset in Infancy (SAVI).
Ma M; Mazumder S; Kwak H; Adams M; Gregory M
J Clin Immunol; 2020 Nov; 40(8):1111-1115. PubMed ID: 32860170
[TBL] [Abstract][Full Text] [Related]
18. Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis.
Nishida T; Nakano K; Inoue Y; Narumi-Kishimoto Y; Kaname T; Akashi K; Tanaka Y
Intern Med; 2021 Apr; 60(7):1109-1114. PubMed ID: 33162473
[TBL] [Abstract][Full Text] [Related]
19. Type I interferon-independent T cell impairment in a Tmem173 N153S/WT mouse model of STING associated vasculopathy with onset in infancy (SAVI).
Siedel H; Roers A; Rösen-Wolff A; Luksch H
Clin Immunol; 2020 Jul; 216():108466. PubMed ID: 32470544
[TBL] [Abstract][Full Text] [Related]
20. A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.
Bennion BG; Ingle H; Ai TL; Miner CA; Platt DJ; Smith AM; Baldridge MT; Miner JJ
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
